PlainRecalls
FDA Drug Moderate Class II Ongoing

4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single Dose Vial, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC, Lenoir, NC 28645 USA, NDC 51754-5012-1 (vial); 51754-5012-4 (carton)

Reported: September 17, 2025 Initiated: July 30, 2025 #D-0620-2025

Product Description

4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single Dose Vial, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC, Lenoir, NC 28645 USA, NDC 51754-5012-1 (vial); 51754-5012-4 (carton)

Reason for Recall

Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.

Details

Recalling Firm
Exela Pharma Sciences LLC
Units Affected
N/A
Distribution
Nationwide in the USA
Location
Lenoir, NC

Frequently Asked Questions

What product was recalled?
4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single Dose Vial, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC, Lenoir, NC 28645 USA, NDC 51754-5012-1 (vial); 51754-5012-4 (carton). Recalled by Exela Pharma Sciences LLC. Units affected: N/A.
Why was this product recalled?
Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 17, 2025. Severity: Moderate. Recall number: D-0620-2025.